Last refreshed: July 21, 2026 (US ET)
Back to holdings

ALGN

Growth

ALIGN TECHNOLOGY INC.

Health Care·Health Care Supplies

Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth.

Close · 3M

+0.00%

ALGN · 3M

+0.00%

Pinch / wheel to zoom · drag to pan · double-tap to reset

Held by 1 AI ETF

QRFT0.030%

as of Jul 8

Signal performance

Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.

Buy signals2
Win rate100% (2/2)
Avg buy return+1.46%
QRFTnow 0.030% of fund1 signal

QRFT · New entry · 1d

weight 0 → 0.030% (new)·stock down 8.6% in the 30 days before

Mar 20·entry $173.18·now $175.05Fresh

+1.08%
since Mar 20
AIEQno longer held7 signals

AIEQ · Exit · 1d

The weight change for ALGN shows a minor, oscillating allocation between 0.08% and 0.09% for several days, preceding its full removal from the portfolio on July 1st. This short-term, fluctuating presence followed by an abrupt exit aligns with AIEQ's strategy as a high-turnover fund that rebalances daily, responding quickly to new information from its IBM Watson NLP engine. Despite ALGN’s recent 30-day return of +17.0% pushing it to 88% of its 52-week high, the fund’s AI likely assessed that its modest 2.89% revenue growth and PER of 30.79 did not justify a continued position. Watson's daily analysis, incorporating news, sentiment, and fundamental data, probably flagged a deterioration in ALGN’s combined appeal, causing its ranking to fall below the threshold for a broad market, sentiment-hybrid portfolio.

weight 0.080% → 0 (exited)·stock up 6.9% in the 30 days before

Jul 1·entry $181.49·now $175.05

-3.55%
since Jul 1

AIEQ · Weight decrease · 2d

AIEQ's daily rebalancing, informed by IBM Watson NLP's continuous analysis of vast data sources, prompted a decisive consecutive weight decrease in ALGN. The AI's output, feeding into EquBot's risk overlay, likely identified deteriorating sentiment or fundamental shifts for the Health Care sector company, leading to the substantial portfolio adjustment. This rapid reduction from 0.63% to a mere 0.08% on May 30th closely followed ALGN's 30-day return of -8.0% at its $174.95 price level, indicating the fund's sensitivity to recent market movements. The AI's broad market, fundamentals-plus-sentiment hybrid style likely processed ALGN's modest 2.89% revenue growth and current price at 84% of its 52-week high as signals warranting a swift de-risking within its typically high-turnover portfolio.

weight 0.640% → 0.080% (-0.560 pp)·stock down 1.9% in the 30 days before

May 30·entry $169.77·now $175.05

+3.11%
since May 30

AIEQ · Weight decrease · 4d

Align Technology Inc. (ALGN) currently trades at $157.25, placing it at 76% of its 52-week high of $207.19, reflecting recent price weakness with 30-day and 1-year returns of -8.5% and -11.5%, respectively. Amidst this downward price trajectory, AIEQ's IBM Watson NLP engine, known for ingesting daily news, social posts, and financial filings, likely identified a consistently less favorable sentiment or deteriorating outlook for ALGN. Given AIEQ's fundamentals plus sentiment hybrid style and daily rebalancing schedule, the consecutive reduction in ALGN's weight from 0.69% to 0.62% suggests a persistent decline in the stock's daily ranking. This systematic reduction indicates the fund's AI-driven overlay is actively reducing exposure to ALGN at this price level, considering its modest revenue growth of 2.89% and ROE of 10.7% in conjunction with the perceived negative information flow.

weight 0.670% → 0.620% (-0.050 pp)·stock down 15.0% in the 30 days before

May 17·entry $158.78·now $175.05

+10.25%
since May 17

AIEQ · Weight decrease · 3d

ALIGN TECHNOLOGY INC. presents a PER of 26.2, a PBR of 2.77, and a revenue growth of 2.89%, coupled with an ROE of 10.7%. These figures suggest a company with moderate growth and profitability metrics, which, for AIEQ's fundamentals + sentiment hybrid investment style, might not signal strong conviction for an increased allocation without compelling sentiment signals. The consistent decrease in ALGN's weight within AIEQ, particularly from May 12th when it shifted from 0.67% to 0.65% and continued downward, directly follows the stock’s prior underperformance, showing a -8.5% return over the last 30 days and -5.7% over 90 days. This pattern suggests that IBM Watson NLP, which powers Amplify ETFs' AIEQ by ingesting vast amounts of financial and social data, likely identified a sustained lack of positive sentiment or emerging negative trends that outweighed the stock's current valuation at $157.25, around 76% of its 52-week high. Given AIEQ's high-turnover strategy and daily rebalancing, even a slight shift in sentiment or fundamental outlook detected by the AI could trigger a continuous reduction in exposure, aiming to optimize the portfolio quickly based on its dynamic daily rankings.

weight 0.670% → 0.630% (-0.040 pp)·stock down 15.0% in the 30 days before

May 15·entry $157.25·now $175.05

+11.32%
since May 15

AIEQ · Weight decrease · 2d

The AI ETF likely initiated consecutive weight decreases for ALGN because its relatively high PER (26.35) and moderate PBR (2.77) appear stretched when contrasted with its modest 2.89% revenue growth. This indicates the algorithm identifies ALGN as potentially overvalued given its current fundamentals, prompting a strategic de-risking within the portfolio. Retail investors should consider this a practical signal to critically re-evaluate if their own holdings, particularly those with similar financial profiles, truly justify their market valuation. It suggests prioritizing companies with stronger growth or more attractive risk-reward metrics.

weight 0.670% → 0.640% (-0.030 pp)·stock down 13.9% in the 30 days before

May 14·entry $160.53·now $175.05

+9.05%
since May 14

AIEQ · Weight decrease · 2d

The AI likely initiated the consecutive weight decrease for ALGN because its high Price-to-Earnings Ratio of 30.63 appears unsupported by its extremely low Revenue Growth of 0.9%. This suggests the company's valuation is not justified by its current fundamental performance, prompting the AI to reduce exposure. For retail investors, this highlights the importance of scrutinizing whether high valuation multiples are backed by strong underlying growth and acting cautiously when a significant disconnect emerges.

weight 0.720% → 0.680% (-0.040 pp)·stock up 4.2% in the 30 days before

May 6·entry $173.94·now $175.05

+0.64%
since May 6

AIEQ · New entry · 1d

The AI ETF likely initiated a new entry into ALGN, despite its current high PER and modest revenue growth, by identifying a significant positive catalyst, strong technical momentum, or an improved forward-looking outlook not captured by these basic trailing financials. This suggests the AI's model detected a favorable shift in market sentiment or specific company dynamics. Retail investors should understand that AI algorithms analyze a wider array of data, including technicals and forward-looking indicators, beyond simple fundamental ratios. Therefore, it's crucial to conduct independent due diligence, researching recent news and future growth drivers, rather than solely relying on limited reported financials when evaluating such moves.

weight 0 → 0.720% (new)·stock up 3.6% in the 30 days before

May 3·entry $171.88·now $175.05Fresh

+1.84%
since May 3

Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.

Buffett-style framework

Fails the frameworkas of Jul 5

The AI ETF AIEQ's recent exit from Align Technology on 2026-07-01 aligns with this analysis's "Fail" verdict. This suggests the AI's algorithm may also be factoring in concerns about the company's valuation or financial health.

  • Circle of CompetenceThe unit economics of dental aligners and scanners, while involving technological evolution, are stable enough to reasonably project future cash flows within a value investor's circle of competence.
  • Economic MoatAlign Technology benefits from strong brand recognition (Invisalign), significant switching costs for dental professionals, and scale advantages as a market leader, contributing to a durable economic moat.
  • ManagementThe provided data does not offer sufficient information to assess management's candidness, capital allocation discipline, or extent of skin in the game.
  • Financial HealthWhile the current ROE of 10.7% meets the single-year minimum, the absence of data on the 10-year average ROE, operating margin stability, and debt levels makes a full assessment of financial health impossible based on the framework's criteria.
  • Margin of SafetyWith a P/E of 30.79 and EV/EBITDA of 20.89 alongside modest revenue growth and current ROE, the current price offers no defensible margin of safety.

While Align Technology operates within a predictable industry and possesses a durable economic moat, an evaluation using this framework raises significant concerns regarding its financial health and current valuation. The lack of sufficient data on management and the company's inability to clearly meet financial health criteria, combined with a high price relative to its current growth and returns, leads to an overall "Fail" verdict.

Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.